{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:43:25Z","timestamp":1783485805257,"version":"3.55.0"},"reference-count":29,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej13-0335","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T23:04:20Z","timestamp":1382396660000},"page":"19-23","source":"Crossref","is-referenced-by-count":10,"title":["A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis"],"prefix":"10.1507","volume":"61","author":[{"given":"Yatsuka","family":"Hibi","sequence":"first","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamae","family":"Ohye","sequence":"additional","affiliation":[{"name":"Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kurahashi","sequence":"additional","affiliation":[{"name":"Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Iwase","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, et al. (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. <i>Oncogene<\/i> 3: 571-578."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Pachnis V, Mankoo B, Costantini F (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. <i>Development <\/i>119: 1005-1017.","DOI":"10.1242\/dev.119.4.1005"},{"key":"3","unstructured":"3. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M (1995) Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. <i>Oncogene<\/i> 10: 191-198."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K et al. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. <i>Proc Natl Acad Sci U S A<\/i> 91: 1579-1583.","DOI":"10.1073\/pnas.91.4.1579"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. <i>Hum Mol Genet<\/i> 2: 851-856.","DOI":"10.1093\/hmg\/2.7.851"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, et al. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. <i>Nature<\/i> 367: 375-376.","DOI":"10.1038\/367375a0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. <i>Nature<\/i> 363: 458-460.","DOI":"10.1038\/363458a0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, et al. (1994) Mutations of the RET proto-oncogene in Hirschsprung&rsquo;s disease. <i>Nature<\/i> 367: 378-380.","DOI":"10.1038\/367378a0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, et al. (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung\u2019s disease. <i>Nature<\/i> 367: 377-378.","DOI":"10.1038\/367377a0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Atti&eacute; T, Pelet A, Edery P, Eng C, Mulligan LM et al. (1995) Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. <i>Hum Mol Genet<\/i> 4: 1381-1386.","DOI":"10.1093\/hmg\/4.8.1381"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Borst MJ, VanCamp JM, Peacock ML, Decker RA (1995) Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung&rsquo;s disease. <i>Surgery<\/i> 117: 386-391.","DOI":"10.1016\/S0039-6060(05)80057-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mulligan LM, Eng C, Atti&eacute; T, Lyonnet S, Marsh DJ, et al. (1994) Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. <i>Hum Mol Genet<\/i> 3: 2163-2167.","DOI":"10.1093\/hmg\/3.12.2163"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Verdy M, Weber AM, Roy CC, Morin CL, Cadotte M, et al. (1982) Hirschsprung&rsquo;s disease in a family with multiple endocrine neoplasia type 2. <i>J Pediatr Gastroenterol Nutr<\/i> 1: 603-607.","DOI":"10.1097\/00005176-198212000-00027"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Decker RA, Peacock ML, Watson P (1998) Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. <i>Hum Mol Genet<\/i> 7: 129-134.","DOI":"10.1093\/hmg\/7.1.129"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Decker RA, Peacock ML (1998) Occurrence of MEN 2a in familial Hirschsprung&rsquo;s disease: a new indication for genetic testing of the RET proto-oncogene.<i> J Pediatr Surg<\/i> 33: 207-214.","DOI":"10.1016\/S0022-3468(98)90433-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takahashi M (2001) The GDNF\/RET signaling pathway and human diseases. <i>Cytokine Growth Factor Rev<\/i> 12: 361-373.","DOI":"10.1016\/S1359-6101(01)00012-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nishikawa M, Murakumo Y, Imai T, Kawai K, Nagaya M, Funahashi H, et al. (2003) Cys611Ser mutation in RET proto-oncogene in a kindred with medullary<b> <\/b>thyroid carcinoma and Hirschsprung&rsquo;s disease. <i>Eur J Hum Genet<\/i> 11: 364-368.","DOI":"10.1038\/sj.ejhg.5200971"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Schuchardt A, D&rsquo;Agati V, Larsson-Blomberg L, Costantini F, Pachnis V (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.<i> Nature<\/i> 367: 380-383.","DOI":"10.1038\/367380a0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ivanchuk SM, Eng C, Cavenee WK, Mulligan LM (1997) The expression of RET and its multiple splice forms in developing human kidney.<i> Oncogene<\/i> 14: 1811-1818.","DOI":"10.1038\/sj.onc.1201016"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Skinner MA, Safford SD, Reeves JG, Jackson ME, Freemerman AJ (2008) Renal aplasia in humans is associated with RET mutations. Am <i>J Hum Genet<\/i> 82: 344-351.","DOI":"10.1016\/j.ajhg.2007.10.008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jeanpierre C, Mac&eacute; G, Parisot M, Morini&egrave;re V, Pawtowsky A, et al. (2011) RET and GDNF mutations are rare in fetuses with renal agenesis or other severe kidney development defects.<i> J Med Genet<\/i> 48: 497-504.","DOI":"10.1136\/jmg.2010.088526"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lor&eacute; F, Di Cairano G, Talidis F (2000) Unilateral renal agenesis in a family with medullary thyroid carcinoma.<i> N Engl J Med<\/i> 342: 1218-1219.","DOI":"10.1056\/NEJM200004203421615"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. McIntyre E, Bond P, Douglas F, Lennard T, Peaston R, et al. (2003) Multiple endocrine neoplasia type 2A: an unusual clinical presentation and association with renal dysplasia. <i>Cancer Genet Cytogenet<\/i> 141: 157-159.","DOI":"10.1016\/S0165-4608(02)00663-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, et al. (2005) A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk.<i> Nature<\/i> 434: 857-863.","DOI":"10.1038\/nature03467"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Saxen L (1987) Organogenesis of the kidney. Cambridge: Cambridge University Press.","DOI":"10.1017\/CBO9780511565083"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Lombardo F, Filetti S, Crocetti U, Schlumberger M (2001) Medullary thyroid carcinoma and lack of renal agenesis. <i>Thyroid<\/i> 11: 93.","DOI":"10.1089\/10507250150500739"},{"key":"27","unstructured":"27. Moore MW, Klein RD, Fari&ntilde;as I, Sauer H, Armanini M, et al. (1996) Renal and neuronal abnormalities in mice lacking GDNF. <i>Nature <\/i>382: 76-79."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski, etal. (2008) Hirschsprung disease, associated syndromes and genetics: a review. <i>J Med Genet<\/i> 45: 1-14.","DOI":"10.1136\/jmg.2007.053959"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Emison ES, Garcia-Barcelo M, Grice EA, Lantieri F, Amiel J, et al. (2010) Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. <i>Am J Hum Genet<\/i> 87: 60-74.","DOI":"10.1016\/j.ajhg.2010.06.007"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/1\/61_EJ13-0335\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T21:01:12Z","timestamp":1646859672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/1\/61_EJ13-0335\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej13-0335","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}